Activation of the Ki-ras gene in spontaneous and chemically induced lung tumors in CD-1 mice - PubMed (original) (raw)
Comparative Study
Activation of the Ki-ras gene in spontaneous and chemically induced lung tumors in CD-1 mice
S Manam et al. Mol Carcinog. 1992.
Abstract
As part of an evaluation of the effectiveness of using ras mutation analysis for distinguishing carcinogen-induced from spontaneous tumors, we examined the profile of ras gene point mutations in spontaneous, 7,12-dimethylbenz[a]anthracene (DMBA)-induced, and N-nitrosodiethylamine (DEN)-induced lung tumors from Crl:CD-1(ICR)BR (CD-1) mice. Although all of the lung tumors were assayed for mutations in the Ha-ras, Ki-ras, and N-ras genes (codons 12, 13, and 61), only Ki-ras mutations were found, which is consistent with other studies that have noted a strong preference for Ki-ras gene activation in mouse, rat, and human lung tumors. We found that spontaneous CD-1 mouse lung tumors had a very high frequency of Ki-ras gene activation (17 of 20 tumors; 85%), distributed among codons 12 (5 of 20), 13 (1 of 20), and 61 (11 of 20). DMBA-induced lung tumors had a slightly higher frequency of Ki-ras gene mutations (16 of 16; 100%), again distributed among codons 12 (5 of 16), 13 (2 of 16), and 61 (9 of 16). However, seven of the DMBA tumors had mutations qualitatively different from those found in spontaneous tumors. In contrast to DMBA-induced tumors, DEN-induced tumors had a lower frequency of Ki-ras mutations (36%) when compared with spontaneous lung tumors, suggesting that DEN primarily induces lung carcinogenesis by a mechanism other than ras gene activation. Thus, although spontaneous and induced CD-1 mouse lung tumors have a strong tissue-specific preference for carrying an activated Ki-ras gene, the nature of the initiating carcinogen can influence the frequency or profile of Ki-ras mutations.
Similar articles
- Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
Manam S, Storer RD, Prahalada S, Leander KR, Kraynak AR, Ledwith BJ, van Zwieten MJ, Bradley MO, Nichols WW. Manam S, et al. Cancer Res. 1992 Jun 15;52(12):3347-52. Cancer Res. 1992. PMID: 1596892 - Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors.
Manam S, Shinder GA, Joslyn DJ, Kraynak AR, Hammermeister CL, Leander KR, Ledwith BJ, Prahalada S, van Zwieten MJ, Nichols WW. Manam S, et al. Carcinogenesis. 1995 May;16(5):1113-9. doi: 10.1093/carcin/16.5.1113. Carcinogenesis. 1995. PMID: 7767973 - Tissue-specific activating mutations of Ha- and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA.
Loktionov A, Hollstein M, Martel N, Galendo D, Cabral JR, Tomatis L, Yamasaki H. Loktionov A, et al. Mol Carcinog. 1990;3(3):134-40. doi: 10.1002/mc.2940030306. Mol Carcinog. 1990. PMID: 1973614 - Activation of proto-oncogenes in human and mouse lung tumors.
Reynolds SH, Anderson MW. Reynolds SH, et al. Environ Health Perspect. 1991 Jun;93:145-8. doi: 10.1289/ehp.9193145. Environ Health Perspect. 1991. PMID: 1773785 Free PMC article. Review. - Role of proto-oncogene activation in carcinogenesis.
Anderson MW, Reynolds SH, You M, Maronpot RM. Anderson MW, et al. Environ Health Perspect. 1992 Nov;98:13-24. doi: 10.1289/ehp.929813. Environ Health Perspect. 1992. PMID: 1486840 Free PMC article. Review.
Cited by
- Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ, Whitsett JA, Koretsky A, Varmus HE. Fisher GH, et al. Genes Dev. 2001 Dec 15;15(24):3249-62. doi: 10.1101/gad.947701. Genes Dev. 2001. PMID: 11751631 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous